Conjugated polymer-based activatable acoustically powered nanomaterials, methods of making and using the same
By synthesizing and modifying conjugated polymers to prepare activatable acoustic-dynamic nanomaterials, the problem of the lack of near-infrared II luminescent acoustic sensitizers in the existing technology has been solved, realizing efficient tumor treatment and drug delivery, and improving the specificity and safety of treatment.
Patent Information
- Application Number
- CN202311144192.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-06
- Publication Date
- 2026-08-25
- Estimated Expiration
- 2043-09-06
AI Technical Summary
The lack of efficient, activatable near-infrared II luminescent sonosensitive agents in the current technology limits the penetration depth of optical diagnosis and treatment, and conventional sonosensitive agents produce side effects in normal tissues. The application of conjugated polymers in sonodynamic therapy has not been reported.
A conjugated polymer was synthesized using 2,6-di(trimethyltin)-4,4-di(2-ethylhexyl)-dithienenocyclopentadiene and 4,7-dibromo-5,6-dinitrobenzo[c][1,2,5]thiadiazole as monomers, and then modified with mesoporous silica to prepare an activatable sonodynamic nanomaterial for near-infrared fluorescence imaging and sonodynamic therapy.
It enables highly efficient sonodynamic therapy guided by near-infrared II fluorescence imaging, improving the specificity of tumor treatment, and achieves drug loading and delivery through mesoporous silica encapsulation, reducing damage to normal tissues.